279 related articles for article (PubMed ID: 17093095)
1. Perturbed interactions of mutant proteolipid protein/DM20 with cholesterol and lipid rafts in oligodendroglia: implications for dysmyelination in spastic paraplegia.
Krämer-Albers EM; Gehrig-Burger K; Thiele C; Trotter J; Nave KA
J Neurosci; 2006 Nov; 26(45):11743-52. PubMed ID: 17093095
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic severity of murine Plp mutants reflects in vivo and in vitro variations in transport of PLP isoproteins.
Thomson CE; Montague P; Jung M; Nave KA; Griffiths IR
Glia; 1997 Aug; 20(4):322-32. PubMed ID: 9262236
[TBL] [Abstract][Full Text] [Related]
3. PLP overexpression perturbs myelin protein composition and myelination in a mouse model of Pelizaeus-Merzbacher disease.
Karim SA; Barrie JA; McCulloch MC; Montague P; Edgar JM; Kirkham D; Anderson TJ; Nave KA; Griffiths IR; McLaughlin M
Glia; 2007 Mar; 55(4):341-51. PubMed ID: 17133418
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the myelin proteolipid protein leads to accumulation of cholesterol and proteolipid protein in endosomes/lysosomes: implications for Pelizaeus-Merzbacher disease.
Simons M; Kramer EM; Macchi P; Rathke-Hartlieb S; Trotter J; Nave KA; Schulz JB
J Cell Biol; 2002 Apr; 157(2):327-36. PubMed ID: 11956232
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody O10 defines a conformationally sensitive cell-surface epitope of proteolipid protein (PLP): evidence that PLP misfolding underlies dysmyelination in mutant mice.
Jung M; Sommer I; Schachner M; Nave KA
J Neurosci; 1996 Dec; 16(24):7920-9. PubMed ID: 8987820
[TBL] [Abstract][Full Text] [Related]
6. Misalignment of PLP/DM20 transmembrane domains determines protein misfolding in Pelizaeus-Merzbacher disease.
Dhaunchak AS; Colman DR; Nave KA
J Neurosci; 2011 Oct; 31(42):14961-71. PubMed ID: 22016529
[TBL] [Abstract][Full Text] [Related]
7. PLP/DM20 expression and turnover in a transgenic mouse model of Pelizaeus-Merzbacher disease.
Karim SA; Barrie JA; McCulloch MC; Montague P; Edgar JM; Iden DL; Anderson TJ; Nave KA; Griffiths IR; McLaughlin M
Glia; 2010 Nov; 58(14):1727-38. PubMed ID: 20629189
[TBL] [Abstract][Full Text] [Related]
8. Genetic background influences UPR but not PLP processing in the rumpshaker model of PMD/SPG2.
McLaughlin M; Karim SA; Montague P; Barrie JA; Kirkham D; Griffiths IR; Edgar JM
Neurochem Res; 2007 Feb; 32(2):167-76. PubMed ID: 16944321
[TBL] [Abstract][Full Text] [Related]
9. Current concepts of PLP and its role in the nervous system.
Griffiths I; Klugmann M; Anderson T; Thomson C; Vouyiouklis D; Nave KA
Microsc Res Tech; 1998 Jun; 41(5):344-58. PubMed ID: 9672418
[TBL] [Abstract][Full Text] [Related]
10. Trafficking of PLP/DM20 and cAMP signaling in immortalized jimpy oligodendrocytes.
Ghandour MS; Feutz AC; Jalabi W; Taleb O; Bessert D; Cypher M; Carlock L; Skoff RP
Glia; 2002 Dec; 40(3):300-11. PubMed ID: 12420310
[TBL] [Abstract][Full Text] [Related]
11. Genotype-phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations. Clinical European Network on Brain Dysmyelinating Disease.
Cailloux F; Gauthier-Barichard F; Mimault C; Isabelle V; Courtois V; Giraud G; Dastugue B; Boespflug-Tanguy O
Eur J Hum Genet; 2000 Nov; 8(11):837-45. PubMed ID: 11093273
[TBL] [Abstract][Full Text] [Related]
12. Differential sensitivity in the survival of oligodendrocyte cell lines to overexpression of myelin proteolipid protein gene products.
Bongarzone ER; Jacobs E; Schonmann V; Kampf K; Campagnoni CW; Campagnoni AT
J Neurosci Res; 2001 Sep; 65(6):485-92. PubMed ID: 11550216
[TBL] [Abstract][Full Text] [Related]
13. Therapy of Pelizaeus-Merzbacher disease in mice by feeding a cholesterol-enriched diet.
Saher G; Rudolphi F; Corthals K; Ruhwedel T; Schmidt KF; Löwel S; Dibaj P; Barrette B; Möbius W; Nave KA
Nat Med; 2012 Jul; 18(7):1130-5. PubMed ID: 22706386
[TBL] [Abstract][Full Text] [Related]
14. Modulation of rumpshaker phenotype with wild-type PLP/DM20 suggests several pathogenic mechanisms.
Barrie JA; Montague P; Karim S; Kirkham D; Nave KA; Anderson TJ; Griffiths IR; McLaughlin M
J Neurosci Res; 2010 Aug; 88(10):2135-45. PubMed ID: 20175203
[TBL] [Abstract][Full Text] [Related]
15. Aberrant trafficking of a proteolipid protein in a mild Pelizaeus-Merzbacher disease.
Koizume S; Takizawa S; Fujita K; Aida N; Yamashita S; Miyagi Y; Osaka H
Neuroscience; 2006 Sep; 141(4):1861-9. PubMed ID: 16844304
[TBL] [Abstract][Full Text] [Related]
16. Proteolipid protein dimerization at cysteine 108: Implications for protein structure.
Daffu G; Sohi J; Kamholz J
Neurosci Res; 2012 Oct; 74(2):144-55. PubMed ID: 22902553
[TBL] [Abstract][Full Text] [Related]
17. A common mechanism of PLP/DM20 misfolding causes cysteine-mediated endoplasmic reticulum retention in oligodendrocytes and Pelizaeus-Merzbacher disease.
Dhaunchak AS; Nave KA
Proc Natl Acad Sci U S A; 2007 Nov; 104(45):17813-8. PubMed ID: 17962415
[TBL] [Abstract][Full Text] [Related]
18. PLP1 gene duplication causes overexpression and alteration of the PLP/DM20 splicing balance in fibroblasts from Pelizaeus-Merzbacher disease patients.
Regis S; Grossi S; Corsolini F; Biancheri R; Filocamo M
Biochim Biophys Acta; 2009 Jun; 1792(6):548-54. PubMed ID: 19376225
[TBL] [Abstract][Full Text] [Related]
19. Oligodendrocytes expressing exclusively the DM20 isoform of the proteolipid protein gene: myelination and development.
Spörkel O; Uschkureit T; Büssow H; Stoffel W
Glia; 2002 Jan; 37(1):19-30. PubMed ID: 11746780
[TBL] [Abstract][Full Text] [Related]
20. Processing of PLP in a model of Pelizaeus-Merzbacher disease/SPG2 due to the rumpshaker mutation.
McLaughlin M; Barrie JA; Karim S; Montague P; Edgar JM; Kirkham D; Thomson CE; Griffiths IR
Glia; 2006 May; 53(7):715-22. PubMed ID: 16506223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
